(Q37897480)

25 August 2017

1 reference

title

Surgical approaches to the treatment of obesity (English)

1 reference

25 August 2017

0 references

Elisabeth A Lambert

3

0 references

John B Dixon

series ordinal

1

object named as

John B Dixon

1 reference

25 August 2017

Nora E Straznicky

2

1 reference

25 August 2017

Markus P Schlaich

series ordinal

4

1 reference

25 August 2017

Gavin W Lambert

series ordinal

5

1 reference

25 August 2017

language of work or name

English

0 references

publication date

5 July 2011

1 reference

Nature Reviews Gastroenterology & Hepatology

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

8

1 reference

25 August 2017

429-437

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2011.112

25 August 2017

0 references

cites work

Bariatric surgery: a history of empiricism, a future in science.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Predicting obesity in young adulthood from childhood and parental obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Is the energy homeostasis system inherently biased toward weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Energy intake in weight-reduced humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Bariatric surgery worldwide 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Bariatric surgery: an IDF statement for obese Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

A proposed clinical staging system for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

M, M, M & M: a mnemonic for assessing obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Referral for a bariatric surgical consultation: it is time to set a standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Systematic review of sleeve gastrectomy as staging and primary bariatric procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Long-term results of laparoscopic sleeve gastrectomy for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Weight loss after laparoscopic adjustable gastric banding is not caused by altered gastric emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

A Review of Seven Years' Experience with Silicone Gastric Banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Narrative review: effect of bariatric surgery on type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Postprandial changes in gut regulatory peptides in gastric bypass patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Sustained weight loss in obese subjects has benefits that are independent of attained weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Depression in association with severe obesity: changes with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Differentiated long-term effects of intentional weight loss on diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Do current body mass index criteria for obesity surgery reflect cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Long-term mortality after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Risk of suicide after long-term follow-up from bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Vagal and hormonal gut-brain communication: from satiation to satisfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Body-Mass Index and Mortality among 1.46 Million White Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Substantial intentional weight loss and mortality in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Direct medical cost of overweight and obesity in the USA: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Indirect costs of obesity: a review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Perioperative safety in the longitudinal assessment of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Band slippage and erosion after laparoscopic gastric banding: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Leaks after sleeve gastrectomy are associated with smaller bougies: prevention and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Laparoscopic gastric plication for treatment of severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Ileal interposition with sleeve gastrectomy for control of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Evidence-based review of the Bioenterics intragastric balloon for weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

The future of bariatrics: endoscopy, endoluminal surgery, and natural orifice transluminal endoscopic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Systematic review: applications and future of gastric electrical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Trends in mortality in bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Systematic review of medium-term weight loss after bariatric operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Laparoscopic sleeve gastrectomy with ileal interposition (SGIT): a modified duodenal switch for resolution of type 2 diabetes mellitus in lesser obese patients (BMI < 35)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Baria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Pouch emptying of solid foods after gastroplasty for morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Changes in satiety, supra- and infraband transit, and gastric emptying following laparoscopic adjustable gastric banding: a prospective follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Sleeve gastrectomy: a restrictive procedure?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Why the Operation I Prefer is Adjustable Gastric Banding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Laparoscopic gastric banding and crural repair in the obese patient with a hiatal hernia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Gastric pacing is not enough: additional measures for an effective obesity treatment program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Inter-disciplinary European guidelines on surgery of severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Management of obesity: summary of SIGN guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.112

Return on investment for bariatric surgery

31 March 2020

1 reference

12 December 2020

Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction

1 reference

12 December 2020

A cost-benefit simulation model of coverage for bariatric surgery among full-time employees.

1 reference

12 December 2020

A study on the economic impact of bariatric surgery.

1 reference

12 December 2020

The cost of overweight and obesity in Australia

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

10.1038/NRGASTRO.2011.112

Identifiers

DOI

1 reference

25 August 2017

1 reference